Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2007-07-31

Original market date: See footnote 1

1998-02-11

Product name:

ATRACURIUM BESYLATE INJECTION

DIN:

02229757 Electronic product monograph is not available

Company:

ABBOTT LABORATORIES, LIMITED
8401 Trans-Canada Highway
Saint-Laurent
Quebec
Canada H4S 1Z1

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

12:20.20 

Anatomical Therapeutic Chemical (ATC): See footnote 4

M03AC04 ATRACURIUM

Active ingredient group (AIG) number:See footnote5

0116898001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
ATRACURIUM BESYLATE 10 MG / ML
Version 4.0.3

"Page details"

Date modified: